ArticlePediatric nephrology (Berlin, Germany)2017
Oral paricalcitol: expanding therapeutic options for pediatric chronic kidney disease patients.
Michael Freundlich et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it